In cancer cells, EGFR heterodimers play an important role in proliferation and migration behavior [65,66,67], which is in accordance with findings from patient studies revealing a significantly adverse disease outcome in cancer patients with overexpressed levels of both receptors compared to those with overexpression of only one receptor species [66,67,68,69]. Here, EGFR is linked to cancer.